{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T23:22:40Z","timestamp":1793834560035,"version":"4.6.1"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ejps.2021.105807","type":"journal-article","created":{"date-parts":[[2021,3,18]],"date-time":"2021-03-18T10:17:06Z","timestamp":1616062626000},"page":"105807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC"],"prefix":"10.1016","volume":"161","author":[{"given":"Shiori","family":"Honda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuki","family":"Fukami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tsujiguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongjie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masataka","family":"Nakano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miki","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejps.2021.105807_bib0001","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1124\/dmd.110.034249","article-title":"Involvement of carboxylesterase 1 and 2 in the hydrolysis of mycophenolate mofetil","volume":"38","author":"Fujiyama","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0002","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1097\/FPC.0b013e32830b0c5e","article-title":"Structure and characterization of human carboxylesterase 1A1, 1A2, and 1A3 genes","volume":"18","author":"Fukami","year":"2008","journal-title":"Pharmacogen. Genom."},{"key":"10.1016\/j.ejps.2021.105807_bib0003","doi-asserted-by":"crossref","first-page":"466","DOI":"10.2133\/dmpk.DMPK-12-RV-042","article-title":"The emerging role of human esterases","volume":"27","author":"Fukami","year":"2012","journal-title":"Drug Metab. Pharmacokinet."},{"key":"10.1016\/j.ejps.2021.105807_bib0004","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ejps.2015.07.006","article-title":"Comparison of substrate specificity between human arylacetamide deacetylase and carboxylesterases","volume":"78","author":"Fukami","year":"2015","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105807_bib0005","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.bcp.2016.07.007","article-title":"Human arylacetamide deacetylase hydrolyzes ketoconazole to trigger hepatocellular toxicity","volume":"116","author":"Fukami","year":"2016","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105807_bib0006","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/PL00005049","article-title":"The transformation of irinotecan (CPT-11) to its active metabolite SN-38 by human liver microsomes. Differential hydrolysis for the lactone and carboxylate forms","volume":"356","author":"Haaz","year":"1997","journal-title":"Naunyn Schmiedeberg's Arch Pharmacol."},{"key":"10.1016\/j.ejps.2021.105807_bib0007","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1124\/dmd.113.051714","article-title":"Prilocaine- and lidocaine-induced methemoglobinemia is caused by human carboxylesterase-, CYP2E1-, and CYP3A4-mediated metabolic activation","volume":"41","author":"Higuchi","year":"2013","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0008","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00335-010-9284-4","article-title":"Recommended nomenclature for five mammalian carboxylesterase gene families: human, mouse, and rat genes and proteins","volume":"21","author":"Holmes","year":"2010","journal-title":"Mamm. Genome"},{"key":"10.1016\/j.ejps.2021.105807_bib0009","first-page":"1189","article-title":"Characterization of CPT-11 hydrolysis by human liver carboxylases isoforms hCE-1 and hCE-2","volume":"60","author":"Humerickhouse","year":"2000","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejps.2021.105807_bib0010","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1124\/dmd.105.004226","article-title":"Identification of esterase expressed in Caco-2 cells and effects of their hydrolyzing activity in predicting human intestinal absorption","volume":"33","author":"Imai","year":"2005","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0011","doi-asserted-by":"crossref","first-page":"48","DOI":"10.2745\/dds.22.48","article-title":"Species differences of drug metabolism","volume":"22","author":"Imai","year":"2007","journal-title":"Drug Delivery System"},{"key":"10.1016\/j.ejps.2021.105807_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejps.2019.105143","article-title":"Strain and sex differences in drug hydrolase activities in rodent livers","volume":"142","author":"Kisui","year":"2020","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105807_bib0013","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1124\/dmd.112.044537","article-title":"Contributions of arylacetamide deacetylase and carboxylesterase 2 to flutamide hydrolysis in human liver","volume":"40","author":"Kobayashi","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0014","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1124\/dmd.111.043067","article-title":"Species differences in tissue distribution and enzyme activities of arylacetamide deacetylase in human, rat, and mouse","volume":"40","author":"Kobayashi","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0015","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1124\/dmd.115.064089","article-title":"Characterization of species differences in tissue diltiazem deacetylation identifies Ces2a as a rat-specific diltiazem deacetylase","volume":"43","author":"Kurokawa","year":"2015","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0016","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1124\/dmd.115.068221","article-title":"Arylacetamide deacetylase is responsible for activation of prasugrel in human and dog","volume":"44","author":"Kurokawa","year":"2016","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0017","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.bcp.2013.10.001","article-title":"N-Glycosylation during translation is essential for human arylacetamide deacetylase enzyme activity","volume":"87","author":"Muta","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105807_bib0018","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1016\/j.bcp.2011.08.003","article-title":"Human arylacetamide deacetylase is responsible for deacetylation of rifamycins: rifampicin, rifabutin, and rifapentine","volume":"82","author":"Nakajima","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejps.2021.105807_bib0019","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1124\/dmd.111.043208","article-title":"Conclusive identification of the oxybutynin-hydrolyzing enzyme in human liver","volume":"40","author":"Sato","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0020","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1124\/jpet.106.111807","article-title":"Anti-influenza prodrug oseltamivir is activated by carboxylesterase human carboxylesterase 1, and the activation is inhibited by antiplatelet agent clopidogrel","volume":"319","author":"Shi","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.ejps.2021.105807_bib0021","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1124\/dmd.113.056184","article-title":"Indiplon is hydrolyzed by arylacetamide deacetylase in human liver","volume":"42","author":"Shimizu","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0022","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1248\/bpb.20.869","article-title":"Hydrolytic profile for ester- or amide-linkage by carboxylesterases pI 5.3 and 4.5 from human liver","volume":"20","author":"Takai","year":"1997","journal-title":"Biol. Pharm. Bull."},{"key":"10.1016\/j.ejps.2021.105807_bib0023","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1124\/dmd.114.059972","article-title":"Systematic identification and characterization of carboxylesterases in cynomolgus macaques","volume":"42","author":"Uno","year":"2014","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0024","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1292\/jvms.14-0496","article-title":"Isolation and characterization of arylacetamide deacetylase in cynomolgus macaques","volume":"77","author":"Uno","year":"2015","journal-title":"J. Vet. Med. Sci."},{"key":"10.1016\/j.ejps.2021.105807_bib0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1080\/00498254.2018.1435927","article-title":"Analysis of carboxylesterase 2 transcript variants in cynomolgus macaque liver","volume":"49","author":"Uno","year":"2018","journal-title":"Xenobiotica"},{"key":"10.1016\/j.ejps.2021.105807_bib0026","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1124\/dmd.109.026567","article-title":"Human arylacetamide deacetylase is a principal enzyme in flutamide hydrolysis","volume":"37","author":"Watanabe","year":"2009","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0027","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1124\/dmd.110.033720","article-title":"Arylacetamide deacetylase is a determinant enzyme for the difference in hydrolase activities of phenacetin and acetaminophen","volume":"38","author":"Watanabe","year":"2010","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ejps.2021.105807_bib0028","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ejps.2017.09.040","article-title":"Difference in substrate specificity of carboxylesterase and arylacetamide deacetylase between dogs and humans","volume":"111","author":"Yoshida","year":"2017","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejps.2021.105807_bib0029","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.pharmthera.2012.12.007","article-title":"Cytochrome P450 enzymes in drug metabolism: regulation of gene expression, enzyme activities, and impact of genetic variation","volume":"138","author":"Zanger","year":"2013","journal-title":"Pharmacol. Ther."}],"container-title":["European Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0928098721001093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T11:58:49Z","timestamp":1760529529000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0928098721001093"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":29,"alternative-id":["S0928098721001093"],"URL":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105807","relation":{},"ISSN":["0928-0987"],"issn-type":[{"value":"0928-0987","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hydrolase activities of cynomolgus monkey liver microsomes and recombinant CES1, CES2, and AADAC","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejps.2021.105807","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"105807"}}